Systemic corticosteroids versus non-steroidal anti-inflammatory drugs for acute gout

Authors

  • Niraphorn Panyaphurikun
  • Pichaya Kamkaew
  • Sukanya Saelim
  • Teerapat Jaisuk

Abstract

OBJECTIVE

to compare pain reduction and adverse events between systemic corticosteroids and NSAIDs in patients with acute gout.

 

METHODS

Four reviewers systematically and independently searched and evaluated from 4 databases including PubMed, the Cochrane Library, Trip database and Scopus. We included all relevant randomized controlled trials (RCTs) comparing efficacy regarding pain reduction and adverse events of systemic corticosteroids and NSAIDs in patients with acute gout by robust inclusion and exclusion criteria. We assessed the methodological quality using validated tools. Then, continuous and dichotomous data were statistically analysed.

 

RESULTS

We include 5 RCTs, involving 834 participants with acute gout in this systematic review. Three RCTs with 624 patients indicated that systemic corticosteroids and NSAIDs were similar efficacy in term of pain reduction at rest using a 100 mm-visual analogue scale (VAS) in the first 6 hours (mean difference [MD] 0.64; 95% confidence interval [CI] -2.26 to 3.54, I2=50%, random-effect model). Two RCTs with 506 participants, systemic corticosteroids were not significantly different from NSAIDs for efficacy in term of pain reduction at activity using a 100 mm-VAS in the first  6 hours (MD -0.28; 95% CI -2.09 to 1.53, I2=0%, fixed-effect model). Three minor adverse events including nausea, vomiting and indigestion were found significantly higher in those using NSAIDs, (relative risk [RR] 0.23; 95% CI 0.11 to 0.51; RR 0.1; 95% CI 0.02 to 0.54 and RR 0.49; 95% CI 0.28 to 0.84, respectively) while rash was more common in those using systemic corticosteroids (RR 4.61; 95% CI 1.34 to 15.81).

 

CONCLUSION

Our study found robust evidence that systemic corticosteroids and NSAIDs have similar efficacy for pain reduction but have lesser adverse events in systemic corticosteroids users. Thus, short-term systemic corticosteroids treatment should be considered as first-line alternative to NSAIDs in patients with acute gout. 

References

Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014 Jan 8;73(8):1470–6.

Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, et al. Gout-Related Health Care Utilization in US Emergency Departments, 2006 Through 2008. Arthritis Care Res. 2013;65(4):571–7.

Kim, Karissa Y et al. "A literature review of the epidemiology and treatment of acute gout." Clinical therapeutics 25.6 (2003): 1593-1617.

Jones R. Nonsteroidal anti-inflammatory drug prescribing: past, present, and future. The American Journal of Medicine. 2001 Jan 8;110(1, Supplement 1):S4–7.

Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, et al. The pattern of use of non-steroidal antiinflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidem Drug Safe. 2008 Aug 1;17(8):822–33.

2016 updated EULAR evidence-based recommendations for the management of gout -- Richette et al. -- Annals of the Rheumatic Diseases [Internet]. [cited 2016 Sep 7]. Available from: http://ard.bmj.com/content/early/2016/07/25/annrheumdis-2016-209707.full

Final_All_about_gout_and_treatment_2014.indd-Final_All_about_gout_and_treatment_2016.pdf [Internet]. [cited 2016 Sep 7].Available from: http:/ /www.ukgoutsociety.org/PDFs/Final_All_about_gout_and_treatment_2016.pdf

Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal antiinflammatory drugs (NSAIDs, aspirin andcoxibs) on upper gastrointestinal tract. Best Practice & Research Clinical Gastroenterology. 2010 Apr;24(2):121–32.

Hernandez-Diaz, Sonia, and Luis Alberto García Rodríguez. "Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic

studies published in the 1990s." Archives of internal medicine 160.14 (2000):2093-2099.

Wolfe, M Michael, David R Lichtenstein,and Gurkirpal Singh. "Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs." New England Journal of Medicine 340.24 (1999): 1888-1899.

Whelton, Andrew. "Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications." The American journal of medicine 106.5 (1999): 13S-24S.

Jones, Roger et al. "Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs." The American journal of medicine 121.6 (2008):464-474.

Imazio M, Brucato A, Forno D, Ferro S, Belli R, Trinchero R, et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis. Heart. 2012 Jul 15;98(14):1078–82.

Colchicine for acute gout - van Echteld -2014 - The Cochrane Library - Wiley Online Library [Internet]. [cited 2016 Sep 7]. Available from: http:/ /onlinelibrary.wiley.com/doi/10.1002/14651858.CD006190.pub2/full

Underwood M. Diagnosis and management of gout. BMJ. 2006 Jun 1;332(7553):1315–9.

Gout_Part_2_ACR-12.pdf [Internet].[cited 2016 Sep 7]. Available from: https://www.rheumatology.org/Portals/0/Files/Gout_Part_2_ACR-12.pdf

The Management of Gout — NEJM[Internet]. [cited 2016 Sep 7]. Available from: http://www.nejm.org/doi/full/10.1056/nejm199602153340707

Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH.Systemic corticosteroids for acute gout. In: Cochrane Database of Systematic Reviews

[Internet]. John Wiley & Sons, Ltd; 2008 [cited 2016 Sep 7]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005521.pub2/abstract

Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C. Use of

oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. The Lancet. 2008 Jun 6;371(9627):1854–60.

Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout. - PubMed - NCBI [Internet]. [cited 2016 Sep 7]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24472084

Oral Prednisolone in the Treatment ofAcute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized TrialOral Prednisolone in the Treatment of Acute Gout | Annals of Internal Medicine

[Internet]. [cited 2016 Sep 7]. Available from: http://annals.org/article.aspx?articleid=2494539

Xu L, Liu S, Guan M, Xue Y. Comparison of Prednisolone , Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial. Med Sci Monit.

;22:810–7.

Cochrane Handbook for Systematic Reviews of Interventions [Internet]. [cited 2016 Aug 28]. Available from: http://handbook.cochrane.org/

Shamseer, Larissa et al. "Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation." Bmj 349 (2015): g7647.

Appendix: Jadad Scale for Reporting Randomized Controlled Trials - Evidencebased Obstetric Anesthesia - Wiley Online Library [Internet]. [cited 2016 Sep 7]. Available from: http:/ /onlinelibrary.wiley.com/doi/ 10.1002/9780470988343.app1/pdf

Comparison of Oral Prednisolone/ Paracetamol and Oral Indomethacin/ Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled Trial [Internet]. [cited 2016 Sep 14]. Available from: http:/ /www.sciencedirect.com/science/article/pii/ S0196064406025388

Commissioner O of the. Reporting Serious Problems to FDA - What is a Serious Adverse Event? [Internet]. [cited 2016 Sep 10]. Available from: http:// www.fda.gov/Safety/MedWatch/ HowToReport/ucm053087.htm

Non-steroidal anti-inflammatory drugs for acute gout - van Durme - 2014 - The Cochrane Library - Wiley Online Library [Internet]. [cited 2016 Sep 12]. Available from: http://onlinelibrary.wiley.com/doi/ 10.1002/14651858.CD010120.pub2/full 2 9 . E a r l y e m e r g e n c y d e p a r t m e n t treatment of acute asthma with systemic corticosteroids - Rowe - 2001 - The Cochrane Library - Wiley Online Library [Internet]. [cited 2016 Sep 14]. Available from: http://onlinelibrary.wiley.com/doi/ 10.1002/14651858.CD002178/full

Short-term low-dose corticosteroids vs place bo and non steroid a lantiinflammatory drugs in rheumatoid arthritis - Gøtzsche - 2005 - The Cochrane Library - Wiley Online Library [Internet]. [cited 2016 Sep 14]. Available from: http://onlinelibrary.wiley.com/doi/ 10.1002/14651858.CD000189.pub2/full

Oral prednisolone is more costeffective than oral indometha...: European Journal of Emergency Medicine [Internet]. [cited 2016 Sep 14]. Available from: http://journals.lww.com/euroemergencymed/pages/articleviewer.aspx? year=2009&issue=10000&article=0000 6&type=abstract

Clinical practice guidelines for management of gout. | National Guideline Clearinghouse [Internet]. [cited 2016 Sep 1 6 ]. Available from: https:/ /www.guideline.gov/summaries/summary/47897

Downloads

Published

2019-09-01

How to Cite

Panyaphurikun, N., Kamkaew, P., Saelim, S., & Jaisuk, T. (2019). Systemic corticosteroids versus non-steroidal anti-inflammatory drugs for acute gout. The Clinical Academia, 43(4), 112–126. Retrieved from https://he02.tci-thaijo.org/index.php/theclinicalacademia/article/view/227052